Don't Overlook These Top Medical Stocks as Q1 Earnings Approach [Yahoo! Finance]
Ligand Pharmaceuticals Incorporated (LGND)
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ligand.com
Company Research
Source: Yahoo! Finance
points out, had it not been for the substantial earnings contribution of the Mag 7, Q1 earnings growth for the rest of the S&P 500 index would be in negative territory. That said, several top-rated Zacks Medical sector stocks are standing out ahead of their Q1 reports on Tuesday, May 7. With now looking like an ideal to invest in their growth, here are three of these top healthcare companies to consider as earnings approach. Ligand Pharmaceuticals LGND Zacks Rank #1 (Strong Buy) Focused on the development and licensing of biopharmaceutical assets, Ligand Pharmaceuticals has been able to enter several licensing deals and generate royalties through its Captisol formulation technology which improves the safety and overall use of drugs including their solubility, bioavailability, smell, and taste. Ligand Pharmaceuticals' Q1 earnings are expected at $1.13 a share following a very tough-to-compete against prior year quarter that saw EPS at $2.28. Still, annual earnings are project
Show less
Read more
Impact Snapshot
Event Time:
LGND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGND alerts
High impacting Ligand Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
LGND
News
- Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade [Yahoo! Finance]Yahoo! Finance
- Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]Yahoo! Finance
- Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year? [Yahoo! Finance]Yahoo! Finance
- Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023) [Yahoo! Finance]Yahoo! Finance
- Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates [Yahoo! Finance]Yahoo! Finance
LGND
Earnings
- 5/7/24 - Beat
LGND
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/17/24 - Form 144
- LGND's page on the SEC website